Show simple item record

Serum endocan levels in patients with stable COPD

dc.contributor.authorBingol, Zuleyha
dc.contributor.authorKiyan, Esen
dc.contributor.authorPihtili, Aylin
dc.date.accessioned2021-03-03T12:18:57Z
dc.date.available2021-03-03T12:18:57Z
dc.identifier.citationPihtili A., Bingol Z., Kiyan E., "Serum endocan levels in patients with stable COPD", INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, cilt.13, ss.3367-3372, 2018
dc.identifier.issn1178-2005
dc.identifier.otherav_2d4581a4-7ccc-445d-ab3c-add32e2f1244
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/35056
dc.identifier.urihttps://doi.org/10.2147/copd.s182731
dc.description.abstractBackground: Endothelial cell specific molecule-1, also called as endocan, is a dermatan sulfate proteoglycan, which is expressed by endothelial cells in alveolar walls of the lung and kidney. High endocan levels are found associated with endothelial dysfunction and inflammation. We hypothesize that endocan level is also high in COPD due to systemic inflammation and endothelial dysfunction. We aimed to investigate the expression of endocan in patients with stable COPD.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectSOLUNUM SİSTEMİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectGöğüs Hastalıkları ve Allerji
dc.titleSerum endocan levels in patients with stable COPD
dc.typeMakale
dc.relation.journalINTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume13
dc.identifier.startpage3367
dc.identifier.endpage3372
dc.contributor.firstauthorID249221


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record